Antibody Treatment
-
{
- All
- News
- Videos
-
Medical Breakthrough: Study Finds New Treatment Effective For Rare Liver Disease
- Wednesday December 24, 2025
- Health | Indo-Asian News Service
A new monoclonal antibody treatment has shown promising results for a rare liver disease called primary sclerosing cholangitis (PSC).
-
www.ndtv.com/health
-
New UCLA Therapy Shows Promise in Preventing Heart Failure After Heart Attacks
- Thursday October 31, 2024
- Written by Gadgets 360 Staff
UCLA’s Broad Center researchers have developed an antibody therapy to help the heart heal after a heart attack. This therapy, which blocks the ENPP1 protein, reduces scar tissue formation that can lead to heart failure. Early tests showed that treated animals had less scarring and a reduced risk of severe heart failure. With plans for human trial...
-
www.gadgets360.com
-
All 37 Omicron Mutations Defeated By This New Antibody Treatment
- Wednesday December 8, 2021
- World News | Deirdre Hipwell, Bloomberg
GlaxoSmithKline Plc said research shows its Covid-19 antibody treatment is effective against the full combination of mutations in the new omicron variant.
-
www.ndtv.com
-
WHO Recommends Antibody Treatment For Critical Covid Patients. Details Here
- Friday September 24, 2021
- World News | Press Trust of India
COVID-19 patients at high risk of hospitalisation or those with severe disease should be given a combination of two antibody treatments, according to latest World Health Organisation guidelines published in The BMJ today.
-
www.ndtv.com
-
Monoclonal Antibody Treatment Combo Cuts Hospitalisation Among High-Risk Covid Patients: Study
- Tuesday August 31, 2021
- World News | Press Trust of India
A combination of 2 monoclonal antibody treatments keeps high-risk Covid patients out of the hospital when infected with mild to moderate disease, according to an observational study published in The Lancet's EClinicalMedicine journal.
-
www.ndtv.com
-
US Pharma Firm Lilly Pauses COVID Antibody Treatment Trial Over Safety Concern
- Wednesday October 14, 2020
- World News | Agence France-Presse
US pharmaceutical firm Eli Lilly on Tuesday paused a late-stage trial of its experimental lab-produced antibody treatment against Covid-19 over an unspecified safety concern, the company said.
-
www.ndtv.com
-
Medical Breakthrough: Study Finds New Treatment Effective For Rare Liver Disease
- Wednesday December 24, 2025
- Health | Indo-Asian News Service
A new monoclonal antibody treatment has shown promising results for a rare liver disease called primary sclerosing cholangitis (PSC).
-
www.ndtv.com/health
-
New UCLA Therapy Shows Promise in Preventing Heart Failure After Heart Attacks
- Thursday October 31, 2024
- Written by Gadgets 360 Staff
UCLA’s Broad Center researchers have developed an antibody therapy to help the heart heal after a heart attack. This therapy, which blocks the ENPP1 protein, reduces scar tissue formation that can lead to heart failure. Early tests showed that treated animals had less scarring and a reduced risk of severe heart failure. With plans for human trial...
-
www.gadgets360.com
-
All 37 Omicron Mutations Defeated By This New Antibody Treatment
- Wednesday December 8, 2021
- World News | Deirdre Hipwell, Bloomberg
GlaxoSmithKline Plc said research shows its Covid-19 antibody treatment is effective against the full combination of mutations in the new omicron variant.
-
www.ndtv.com
-
WHO Recommends Antibody Treatment For Critical Covid Patients. Details Here
- Friday September 24, 2021
- World News | Press Trust of India
COVID-19 patients at high risk of hospitalisation or those with severe disease should be given a combination of two antibody treatments, according to latest World Health Organisation guidelines published in The BMJ today.
-
www.ndtv.com
-
Monoclonal Antibody Treatment Combo Cuts Hospitalisation Among High-Risk Covid Patients: Study
- Tuesday August 31, 2021
- World News | Press Trust of India
A combination of 2 monoclonal antibody treatments keeps high-risk Covid patients out of the hospital when infected with mild to moderate disease, according to an observational study published in The Lancet's EClinicalMedicine journal.
-
www.ndtv.com
-
US Pharma Firm Lilly Pauses COVID Antibody Treatment Trial Over Safety Concern
- Wednesday October 14, 2020
- World News | Agence France-Presse
US pharmaceutical firm Eli Lilly on Tuesday paused a late-stage trial of its experimental lab-produced antibody treatment against Covid-19 over an unspecified safety concern, the company said.
-
www.ndtv.com